VAERS Explorer
Back to explore

Report #2839326

Received May 3, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Unknown
Age
Age unknown
State
IA
Recovered
Unknown
Vaccinated
Apr 30, 2025
Onset
Apr 30, 2025
Days to onset
0
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
MMRVMEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD)MERCK & CO. INC.1X023401—

Symptoms (2)

Expired product administeredNo adverse event

Symptom narrative

No additional AE/PQC reported; Nurse called to report that an expired dose of PROQUAD was administered to 1 patient. Caller stated the product expired 3/20/2025 and was administered 4/30/2025. Caller stated product was never involved in a temperature excursion. Caller stated no pa; This spontaneous report was received from a Nurse and refers to a patient of unknown age and gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 30-APR-2025, the patient was vaccinated with the first dose of Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) lot #X023401, expiration date: 20-Mar-2025 (expired product administered) (strength, dose, route, and anatomical location were not provided) for prophylaxis. The vaccine was reconstituted with sterile diluent (MERCK STERILE DILUENT) (no details provided). It was reported that product was never involved in a temperature excursion. No adverse events reported.

Other medications

Sterile diluent